Parallax Volatility Advisers
KURA icon

Parallax Volatility Advisers’s Kura Oncology KURA Stock Holding History

Parallax Volatility Advisers’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,300
Closed -$248K – 2678
2023
Q1 		$248K Hold
20,300
– – ﹤0.01% 1943
2022
Q4 		$252K Buy
+20,300
New +$295K ﹤0.01% 2074

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Parallax Volatility Advisers's KURA Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of Kura Oncology (KURA) in Q2 2023, closing a stake of 385 shares — an estimated $4.71K sold.

Parallax Volatility Advisers first reported a position in KURA in Q3 2017 and held it in 7 quarters. The position peaked at $150K in Q3 2017. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2023.

  • Parallax Volatility Advisers reported no remaining Kura Oncology position as of Q2 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 385 Kura Oncology shares in Q2 2023, an estimated $4.71K.
  • Parallax Volatility Advisers first reported a position in Kura Oncology in Q3 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's Kura Oncology position peaked at $150K in Q3 2017.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.